<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="and innate immunity. In the lungs of H5N1-infected mice, ZrO2" exact="treatment" post="led to less pathological lung injury, significant reduction in"/>
 <result pre="(NPs) have increasingly been applied as an inexpensive and easy-to-use" exact="detection" post="method as well as a promising adjuvant against viral"/>
 <result pre="It is also used as an anticancer agent in the" exact="treatment" post="of colon cancer.31 Despite their potential biomedical applications, few"/>
 <result pre="lungs of H5N1-infected mice. Treatment with ZrO2 prior to influenza" exact="infection" post="caused prompt initiation of the host antiviral response and"/>
 <result pre="s. Cytokine primers are listed in Table S2. In addition," exact="detection" post="of protein expression of cytokines was performed using ELISA"/>
 <result pre="To study the protective effects of NPs in IAV H5N1" exact="infection" post="in vivo, three kinds of NPs, namely ZrO2, SNs,"/>
 <result pre="died in each of the 200 nm SN and ZrO2" exact="treatment" post="groups, and no deaths were observed in the 200"/>
 <result pre="and no deaths were observed in the 200 nm PS" exact="treatment" post="group. According to the size effect, the survival rate"/>
 <result pre="NPs. To explore whether the effect of NPs against H5N1" exact="infection" post="was dose-dependent, an experiment was performed using ZrO2, SNs,"/>
 <result pre="levels (P &amp;lt; 0.05). Combined with histopathological analyses and the" exact="detection" post="of HA copy numbers, these results confirm that NPs"/>
 <result pre="of antiviral drugs. Therefore, new approaches to fighting influenza virus" exact="infection" post="are urgently needed. Due to unique structure and chemical"/>
 <result pre="NPs can be carried into lung most effectively after viral" exact="infection" post="when compared to 25 mg/kg ZrO2 NPs and 50"/>
 <result pre="nm size and 100 mg/kg dose conferred protection against H5N1" exact="infection" post="in mice (Figure 6). The mechanisms of this protection"/>
 <result pre="immunity in the early stage of H5N1 infection. Appropriate NP" exact="treatment" post="could reduce the viral load and suppress the inflammatory"/>
 <result pre="zirconia NPs suggests strong potential for application of this novel" exact="treatment" post="to a wide range of microbial infections. Figure 6"/>
 <result pre="nm size and 100 mg/kg dose conferred protection against H5N1" exact="infection" post="in mice. The mechanisms are related to ZrO2-mediated enhancement"/>
 <result pre="in the early stage of H5N1 infection. The appropriate nanoparticle" exact="treatment" post="could reduce viral load and suppress the inflammatory cytokine"/>
 <result pre="Vet Microbiol. 2012;155(2–4):207–213. doi:10.1016/j.vetmic.2011.09.01621982127 7.NohJY, YoonSW, KimDJ, et al. Simultaneous" exact="detection" post="of severe acute respiratory syndrome, Middle East respiratory syndrome,"/>
 <result pre="Theory Eng. 2015;7(2):145–148. doi:10.7763/IJCTE.2015.V7.946 15.BurggraafS, KarpalaAJ, BinghamJ, et al. H5N1" exact="infection" post="causes rapid mortality and high cytokine levels in chickens"/>
 <result pre="of immunomodulatory therapy. Cell Mol Immunol. 2016;13(1):3–10. doi:10.1038/cmi.2015.7426189369 45.UyekiTM. Human" exact="infection" post="with highly pathogenic avian influenza A (H5N1) virus: review"/>
</results>
